NASDAQ: VIR · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Vir Biotechnology Inc.

How Vir Biotechnology Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.0B

Price

$11.75

P/E

-7.9

EPS (TTM)

$-1.49

1-year return

98.8%

Dividend yield

0.0%

52-week range

$5.56–$11.75

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources